Brief: AnGes MG and Morishita Jintan signs license agreement
Dec 6 (Reuters) - AnGes MG Inc 4563.T :
* Says it signed license agreement with Morishita Jintan Co
Ltd 4524.T and to grant exclusive development, manufacturing
and sales rights for cervical precancer treatment vaccine to
Morishita Jintan
Source text in Japanese: https://goo.gl/cGnWwU
Further company Coverage: 4563.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))
Recent news on AnGes
See all newsTable: Anges -Q1 group results
Brief: Vasomune Therapeutics, Inc., And Anges, Inc., Announce Us FDA Clearance Of Investigational New Drug (Ind) Application For Pegevongitide (Av-001) Treatment In Resuscitation Of Severely Burned Patients
Table: Anges -2025 parent results
Table: Anges -2025 group results
Brief: Anges & Vasomune Therapeutics Enter Agreement For AV-001